{
    "name": "Informed consent",
    "number": "3",
    "text": "\u00a7671-3\u00a0 Informed consent.\u00a0 (a)\u00a0 The Hawaii medical board may establish standards for health care providers to follow in giving information to a patient, or to a patient's guardian or legal surrogate if the patient lacks the capacity to give an informed consent, to ensure that the patient's consent to treatment is an informed consent.\u00a0 The standards shall be consistent with subsection (b) and may include:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 The substantive content of the information to be given;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 The manner in which the information is to be given by the health care provider; and\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 The manner in which consent is to be given by the patient or the patient's guardian or legal surrogate.\n\u00a0\u00a0\u00a0\u00a0 (b)\u00a0 The following information shall be supplied to the patient or the patient's guardian or legal surrogate prior to obtaining consent to a proposed medical or surgical treatment or a diagnostic or therapeutic procedure:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 The condition to be treated;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 A description of the proposed treatment or procedure;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 The intended and anticipated results of the proposed treatment or procedure;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 The recognized alternative treatments or procedures, including the option of not providing these treatments or procedures;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 The recognized material risks of serious complications or mortality associated with:\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (A)\u00a0 The proposed treatment or procedure;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (B)\u00a0 The recognized alternative treatments or procedures; and\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (C)\u00a0 Not undergoing any treatment or procedure; and\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 The recognized benefits of the recognized alternative treatments or procedures.\n\u00a0\u00a0\u00a0\u00a0 (c)\u00a0 On or before January 1, 1984, the Hawaii medical board shall establish standards for health care providers to follow in giving information to a patient or a patient's guardian, to ensure that the patient's consent to the performance of a mastectomy is an informed consent.\u00a0 The standards shall include the substantive content of the information to be given, the manner in which the information is to be given by the health care provider and the manner in which consent is to be given by the patient or the patient's guardian.\u00a0 The substantive content of the information to be given shall include information on the recognized alternative forms of treatment.\n\u00a0\u00a0\u00a0\u00a0 (d)\u00a0 Nothing in this section shall require informed consent from a patient or a patient's guardian or legal surrogate when emergency treatment or an emergency procedure is rendered by a health care provider and the obtaining of consent is not reasonably feasible under the circumstances without adversely affecting the condition of the patient's health.\n\u00a0\u00a0\u00a0\u00a0 (e)\u00a0 For purposes of this section, \"legal surrogate\" means an agent designated in a power of attorney for health care or surrogate designated or selected in accordance with chapter 327E. [L 1976, c 219, pt of \u00a72; am L 1982, c 95, \u00a71; am L 1983, c 223, \u00a72 superseded by c 284, \u00a71; am L 2003, c 114, \u00a72; am L 2008, c 9, \u00a73]\n\u00a0\nCross References\n\u00a0\n\u00a0 Mental illness, informed consent for nonemergency treatment, see \u00a7334E-1.\n\u00a0\nLaw Journals and Reviews\n\u00a0\n\u00a0 Consent for Testing and Treatment of Minors in Hawaii.\u00a0 13 HBJ, no. 13, at 165 (2009).\n\u00a0 Keomaka v. Zakaib:\u00a0 The Physician's Affirmative Duty to Protect Patient Autonomy Through the Process of Informed Consent.\u00a0 14 UH L. Rev. 801 (1992).\n\u00a0 Holding Hawai\u0091i Nursing Facilities Accountable for the Inadequate Pain Management of Elderly Residents.\u00a0 27 UH L. Rev. 233 (2004).\n\u00a0\nCase Notes\n\u00a0\n\u00a0 Patient-oriented standard applies to physician's duty to disclose risk information prior to treatment.\u00a0 79 H. 475, 904 P.2d 489 (1995).\n\u00a0 Under circumstances of case, physician did not have affirmative duty to inform patient that physician was not plastic surgeon and did not have hospital privileges.\u00a0 86 H. 84, 947 P.2d 952 (1997).\n\u00a0 Where defendant doctor never properly established at trial the \"therapeutic privilege exception\" to the requirement that informed consent be obtained before starting patient on antipsychotic medication, trial court erred in refusing to instruct jury concerning the tort of negligent failure to provide informed consent.\u00a0 98 H. 470, 50 P.3d 946 (2002).\n\u00a0 Circuit court did not err in denying defendant's motion for judgment as a matter of law on plaintiff's informed consent claim as this section requires the physician to inform patients of recognized alternative treatments, and defendant did not show that Hawaii courts have directly held that plaintiffs claiming the failure to disclose an alternative treatment are required to show that they suffered an injury that the physician failed to disclose.\u00a0 125 H. 253, 259 P.3d 569 (2011).\n\u00a0 The circuit court erroneously allowed plaintiffs' standard of care expert to testify that physician owed a duty to disclose physician's and the medical community's experience with the treatment, and that physician failed to meet that obligation, where expert's testimony was contrary to the plain language of this section and Hawaii law.\u00a0 125 H. 253, 259 P.3d 569 (2011).\n\u00a0 Under the patient-oriented standard adopted by Hawaii courts for determining whether particular information must be disclosed to a patient, an alternative dosage can constitute a \"recognized alternative treatment\" within the meaning of subsection (b)(4); where plaintiffs adduced evidence that recognized alternative dosing regimens had a lower risk of steroid myopathy, plaintiffs adduced evidence that a reasonable person would need to hear about the different recognized pulsing methods to make an informed decision.\u00a0 125 H. 253, 259 P.3d 569 (2011).\n\u00a0 Informed consent doctrine discussed.\u00a0 8 H. App. 518, 811 P.2d 478 (1991).\n\u00a0 A consent form is no substitute for a physician's affirmative duty to inform his or her patient.\u00a0 86 H. 93 (App.), 947 P.2d 961 (1997)."
}